Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Reiterates Neutral on Elanco Animal Health, Raises Price Target to $18

Author: Benzinga Newsdesk | March 12, 2024 10:08am
Piper Sandler analyst David Westenberg reiterates Elanco Animal Health (NYSE:ELAN) with a Neutral and raises the price target from $12 to $18.

Posted In: ELAN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist